BASF pursues a capacity expansion of the integrated ethylene oxide complex at its Verbund site in Antwerp
BASF pursues a significant capacity expansion of the integrated ethylene oxide complex at its Verbund site in Antwerp, Belgium. The project includes capacity expansions for ethylene oxide and for several downstream derivatives, such as surfactants.
In Europe, BASF operates ethylene oxide plants in Antwerp and Ludwigshafen with a combined capacity of 845,000 metric tons per year. The company is the largest producer of ethylene oxide derivatives in the region. Major ethylene oxide derivatives are surfactants, ethanol amines, glycol ethers, polyether polyols and other specialty products used in a wide range of industries such as home and personal care, industrial applications and the automotive industry.
BASF intends to further strengthen its backward integration into ethylene oxide to support continued growth of its customers in downstream markets. The final investment decision is expected to be made in 2019.
Categories
Investments
2018-07-23
€ 500 mln at Port Of Antwerp (BE)Chemical substances
Countries
Companies
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
